This trial is to see if a new stent graft system is safe and effective for treating ascending thoracic aortic pathologies.
1 Primary · 0 Secondary · Reporting Duration: 30 days
Awards & Highlights
1 Treatment Group
Type A Dissection
1 of 1
20 Total Participants · 1 Treatment Group
Primary Treatment: Valiant PS-IDE Stent Graft · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are any new participants accepted for this clinical experiment?
"Patient recruitment is currently live for this trial, the details of which were published on clinicaltrials.gov in December 2018 and last updated March 2022." - Anonymous Online Contributor
How many individuals have enlisted in this trial?
"Affirmative. Clinicaltrials.gov attests that this research project, first posted on December 15th 2018 and last updated March 7th 2022 is still recruiting participants. Specifically, they are seeking 20 individuals at a single location." - Anonymous Online Contributor